P. Kaminski et al., THE EFFECT OF SALBUTAMOL TREATMENT ON THE CELLULAR-IMMUNITY OF THE OFFSPRING OF PREGNANT MICE - SPLEEN-CELL ACTIVITY, Drugs under experimental and clinical research, 24(2), 1998, pp. 77-83
Preterm delivery is one of the greatest problems in obstetric care. On
e of the most commonly used treatments for high risk cases is salbutam
ol, a Bp-adrenoceptor agonist The aim of the present study was to dete
rmine if such treatment causes any changes in the neonatal immune syst
em which should therefore be a concern in the care of the newborn. The
experiments were performed on 4 to 5 or 6 to 7-week old female and ma
le offspring of salbutamol-treated C3H/W inbred mice. In the first par
t of the study, the number of spleen cells, phenotypes and activity (p
hytohemagglutinin-induced proliferation, ability to induce local graft
versus host reaction) were determined. We observed lowering of cell n
umber and lowered proportions of cluster of differentiation (CD)3, CD4
and CD8 positive lymphocytes in spleens of progeny of salbutamol-trea
ted mice. However, CD4(+) to CD8(+) ration was higher in the progeny o
f salbutamol-treated mothers than in the corresponding controls. In ad
dition, reactivity to phytohemagglutinin and ability to induce local g
raft vs. host reaction were higher (popliteal lymph node test) or undi
sturbed (lymphocyte-induced angiogenesis test) in this group of mice.